Oxidative Stress and Therapeutic Development in Lung Diseases

Area of Science:

• Pulmonary Medicine
• Biochemistry
• Pathophysiology

Background:

• Oxidative stress, an imbalance between reactive oxygen and nitrogen species (ROS/RNS) and antioxidants, is implicated in lung disease pathogenesis.
• ROS/RNS are produced from various sources and play roles in both normal physiology and disease states.

Purpose of the Study:

• To provide a comprehensive overview of ROS/RNS and antioxidants in the context of lung diseases.
• To discuss the relationship between oxidant/antioxidant imbalance and lung pathophysiology.
• To review current and novel therapeutic strategies for managing oxidative stress in lung diseases.

Main Methods:

• Literature review of scientific articles on oxidative stress, ROS/RNS, antioxidants, and lung diseases.
• Synthesis of information regarding the sources of ROS/RNS, antioxidant defense systems, and their role in disease.
• Analysis of therapeutic approaches, including their limitations and future directions.

Main Results:

• ROS/RNS contribute significantly to the pathogenesis of various lung diseases.
• Antioxidant systems are crucial for maintaining cellular homeostasis, but their capacity can be overwhelmed in disease states.
• Current therapeutic strategies targeting oxidative stress have limitations, and novel approaches are under investigation.

Conclusions:

• Understanding the role of ROS/RNS and antioxidants is vital for comprehending lung disease development.
• Effective therapeutic strategies require addressing the complex interplay of oxidants and antioxidants.
• Further research into novel antioxidant therapies holds promise for improving treatment outcomes in lung diseases.